Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma

The dysregulation of Fbxo4-cyclin D1 axis occurs at high frequency in esophageal squamous cell carcinoma (ESCC), where it promotes ESCC development and progression. However, defining a therapeutic vulnerability that results from this dysregulation has remained elusive. Here we demonstrate that Rb an...

Descripción completa

Detalles Bibliográficos
Autores principales: Qie, Shuo, Yoshida, Akihiro, Parnham, Stuart, Oleinik, Natalia, Beeson, Gyda C., Beeson, Craig C., Ogretmen, Besim, Bass, Adam J., Wong, Kwok-Kin, Rustgi, Anil K., Diehl, J. Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428878/
https://www.ncbi.nlm.nih.gov/pubmed/30899002
http://dx.doi.org/10.1038/s41467-019-09179-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428878/
https://www.ncbi.nlm.nih.gov/pubmed/30899002
http://dx.doi.org/10.1038/s41467-019-09179-w

Ejemplares similares